Number of the records: 1
Chemotherapy, IL-12 gene therapy and combined adjuvant therapy of HPV 16-associated MHC class I-proficient and -deficient tumours
SYS 0024471 LBL 02776^^^^^2200349^^^450 005 20240103181049.7 100 $a 20051213d m y slo 03 ba 101 0-
$a eng $d eng 102 $a GR 200 1-
$a Chemotherapy, IL-12 gene therapy and combined adjuvant therapy of HPV 16-associated MHC class I-proficient and -deficient tumours 215 $a 8 s. 463 -1
$1 001 cav_un_epca*0256808 $1 011 $a 1019-6439 $e 1791-2423 $1 200 1 $a International Journal of Oncology $v Roč. 28, č. 1 (2006), s. 253-260 $1 210 $c Spandidos Publications 541 1-
$a Chemoterapie, genová terapie IL-12 a kombinovaná adjuvantní terapie MHC I+ a MHC I- nádorů vyvolaných HP 16 $z cze 610 0-
$a HPV16 610 0-
$a MHC class I-deficient and MHC class I-proficient tumour cells 610 0-
$a CMRTD 700 -1
$3 cav_un_auth*0105388 $a Indrová $b Marie $p UMG-J $w Laboratory of Transgenic Models of Diseases $4 070 $T Ústav molekulární genetiky AV ČR, v. v. i. 701 -1
$3 cav_un_auth*0105320 $a Bieblová $b Jana $p UMG-J $w Laboratory of Transgenic Models of Diseases $4 070 $T Ústav molekulární genetiky AV ČR, v. v. i. 701 -1
$3 cav_un_auth*0105390 $a Jandlová $b Táňa $p UMG-J $4 070 $T Ústav molekulární genetiky AV ČR, v. v. i. 701 -1
$3 cav_un_auth*0020321 $a Vonka $b V. $y CZ $4 070 701 -1
$3 cav_un_auth*0015365 $a Pajtasz-Piasecka $b E. $y PL $4 070 701 -1
$3 cav_un_auth*0105479 $a Reiniš $b Milan $p UMG-J $w Laboratory of Transgenic Models of Diseases $4 070 $T Ústav molekulární genetiky AV ČR, v. v. i.
Number of the records: 1